Confidently choose the right candidates to move forward by initiating non-GLP toxicology studies alongside in vivo studies. Integrate pharmacology and pathology into your toxicology study to proactively resolve issues earlier in the journey — and more affordably.
Nonclinical Safety and Efficacy
Complete a single study or the package of studies you need to support your IND/CTA enabling program with a deep bench of study design expertise. Couple that with high quality study execution to confidently de-risk your molecule.
Ensure the quality of your precious molecule through specialized analytical testing expertise to help you identify, assess and demonstrate control throughout its development and commercialization.
Complete a full IND/CTA-enabling program in as little as 6 months, with a prospective plan, accelerated timeline and expert guidance that ensures you’re set and ready to advance confidently into the clinic.